SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001356576-24-000039
Filing Date
2024-07-23
Accepted
2024-07-23 16:20:54
Documents
15
Period of Report
2024-07-23
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K supn-20240723.htm   iXBRL 8-K 27213
2 EX-99.1 ex99107-23x2024.htm EX-99.1 8894
6 SUPERNUS LOGO image_0.jpg GRAPHIC 5496
  Complete submission text file 0001356576-24-000039.txt   169383

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT supn-20240723.xsd EX-101.SCH 1917
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT supn-20240723_lab.xml EX-101.LAB 21884
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT supn-20240723_pre.xml EX-101.PRE 12522
17 EXTRACTED XBRL INSTANCE DOCUMENT supn-20240723_htm.xml XML 2727
Mailing Address 9715 KEY WEST AVENUE ROCKVILLE MD 20850
Business Address 9715 KEY WEST AVENUE ROCKVILLE MD 20850 301-838-2500
SUPERNUS PHARMACEUTICALS, INC. (Filer) CIK: 0001356576 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35518 | Film No.: 241134687
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)